A single dose, randomized, open label, pharmacokinetic and pharmacodynamic study of inhaled insulin in a 3 way crossover comparison against the innovators Humalog KwikPen for injection and the AFREZZA Inhalation Powder Cartridge conducted under fasting conditions in healthy male and female volunteers

Trial Profile

A single dose, randomized, open label, pharmacokinetic and pharmacodynamic study of inhaled insulin in a 3 way crossover comparison against the innovators Humalog KwikPen for injection and the AFREZZA Inhalation Powder Cartridge conducted under fasting conditions in healthy male and female volunteers

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 08 Jul 2016

At a glance

  • Drugs Insulin (Primary)
  • Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Zenith Technology Corporation
  • Most Recent Events

    • 08 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top